Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 3Polycystic Ovary Syndrome 1Cardiovascular Diseases 1

Interventions

Vitamin D 2Cholecalciferol 2Aspirin 2Vorinostat 1Vitamin E 1Raloxifene Hydrochloride 1Progestins 1Hormone Replacement Therapy 1Fish Oils 1Fatty Acids, Omega-3 1Estrogens 1Estrogen Replacement Therapy 1Dietary Supplements 1Diet, Fat-Restricted 1Calcium 1Bortezomib 1Antioxidants 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Cardiovascular Diseases × Raloxifene Hydrochloride × Clear all
NCT00190593 2007-01-26

Raloxifene Use for The Heart

Eli Lilly and Company

Phase 3 Completed
10,000 enrolled
Breast

Breast Neoplasms, Cardiovascular Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡